Oxidized low‐density lipoprotein, lipid and calcium aggregates reveal oxidative stress and inflammation in the conjunctiva of glaucoma patients

Conjunctival specimens from primary open‐angle glaucoma (POAG), exfoliation glaucoma (ExG) patients and controls were histologically analysed for oxidized low‐density lipoprotein (ox‐LDL), lipid and calcium aggregates. Our goal was to use them as biomarkers of oxidative stress and inflammation and to evaluate their correlation with glaucoma and impact on surgical outcome.

[1]  G. Damonte,et al.  From DNA damage to functional changes of the trabecular meshwork in aging and glaucoma , 2016, Ageing Research Reviews.

[2]  H. Uusitalo,et al.  Matrix metalloproteinases (MMP‐1, MMP‐2, MMP‐3 and MMP‐9, and TIMP‐1, TIMP‐2 and TIMP‐3) and markers for vascularization in functioning and non‐functioning bleb capsules of glaucoma drainage implants , 2015, Acta ophthalmologica.

[3]  H. Uusitalo,et al.  Conjunctival matrix metalloproteinases and their inhibitors in glaucoma patients , 2015, Acta ophthalmologica.

[4]  M. Longobardi,et al.  Genomic and post-genomic effects of anti-glaucoma drugs preservatives in trabecular meshwork. , 2015, Mutation research.

[5]  H. Uusitalo,et al.  Immunohistochemical analysis of extracellular matrix bleb capsules of functioning and non‐functioning glaucoma drainage implants , 2014, Acta ophthalmologica.

[6]  Ronald Klein,et al.  Markers of inflammation, oxidative stress, and endothelial dysfunction and the 20-year cumulative incidence of early age-related macular degeneration: the Beaver Dam Eye Study. , 2014, JAMA ophthalmology.

[7]  A. Gafencu,et al.  The involvement of the monocytes/macrophages in chronic inflammation associated with atherosclerosis. , 2013, Immunobiology.

[8]  R. Ogawa,et al.  Roles of lipid metabolism in keloid development , 2013, Lipids in Health and Disease.

[9]  T. Yoneda,et al.  Involvement of toll-like receptor 2 and 4 in association between dyslipidemia and osteoclast differentiation in apolipoprotein E deficient rat periodontium , 2013, Lipids in Health and Disease.

[10]  A. Izzotti,et al.  New proteins as vascular biomarkers in primary open angle glaucomatous aqueous humor. , 2012, Investigative ophthalmology & visual science.

[11]  Hannu Uusitalo,et al.  Mitomycin C‐augmented deep sclerectomy in primary open‐angle glaucoma and exfoliation glaucoma: a three‐year prospective study , 2011, Acta ophthalmologica.

[12]  C. Birt,et al.  Preservative Exposure and Surgical Outcomes in Glaucoma Patients: The PESO Study , 2011, Journal of glaucoma.

[13]  H. Uusitalo,et al.  Conjunctival Inflammatory Cells and Their Predictive Role For Deep Sclerectomy in Primary Open-angle Glaucoma and Exfoliation Glaucoma , 2011, Journal of glaucoma.

[14]  A. Izzotti,et al.  Ability of dorzolamide hydrochloride and timolol maleate to target mitochondria in glaucoma therapy. , 2011, Archives of ophthalmology.

[15]  S. Bhartiya,et al.  Surgical management of glaucoma: Evolving paradigms , 2011, Indian journal of ophthalmology.

[16]  B. Aggarwal,et al.  Oxidative stress, inflammation, and cancer: how are they linked? , 2010, Free radical biology & medicine.

[17]  H. Uusitalo,et al.  Mitomycin‐C‐augmented deep sclerectomy in patients with primary open‐angle glaucoma and exfoliation glaucoma: a 1‐year prospective study , 2010, Acta ophthalmologica.

[18]  B. Schieffer,et al.  The secretory phospholipase A2 group IIA: a missing link between inflammation, activated renin-angiotensin system, and atherogenesis? , 2008, Vascular health and risk management.

[19]  H. Uusitalo,et al.  Phospholipases A2 in normal human conjunctiva and from patients with primary open-angle glaucoma and exfoliation glaucoma , 2008, Graefe's Archive for Clinical and Experimental Ophthalmology.

[20]  H. Uusitalo,et al.  Matrix metalloproteinases and their inhibitors in the chamber angle of normal eyes and patients with primary open-angle glaucoma and exfoliation glaucoma , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.

[21]  H. Uusitalo,et al.  Phospholipase A2 in chamber angle of normal eyes and patients with primary open angle glaucoma and exfoliation glaucoma , 2007, Molecular vision.

[22]  W. Koenig,et al.  Biomarkers of Atherosclerotic Plaque Instability and Rupture , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[23]  G. Hotamisligil,et al.  Inflammation and metabolic disorders , 2006, Nature.

[24]  F. Tang,et al.  Hypercholesterolemia Accelerates Vascular Calcification Induced by Excessive Vitamin D via Oxidative Stress , 2006, Calcified Tissue International.

[25]  H. Uusitalo,et al.  Deep sclerectomy for the treatment of exfoliation and primary open-angle glaucoma. , 2006, Acta ophthalmologica Scandinavica.

[26]  Don H. Anderson,et al.  Age‐related macular degeneration—emerging pathogenetic and therapeutic concepts , 2006, Annals of medicine.

[27]  Andreas Hald,et al.  Oxidative stress and inflammation in Parkinson's disease: is there a causal link? , 2005, Experimental Neurology.

[28]  P. Khaw,et al.  Primary open-angle glaucoma , 2004, The Lancet.

[29]  C. Creuzot-Garcher,et al.  Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study. , 2004, Investigative ophthalmology & visual science.

[30]  C. Abrass.  Cellular Lipid Metabolism and the Role of Lipids in Progressive Renal Disease , 2004, American Journal of Nephrology.

[31]  G. Getz,et al.  Site Specificity of Atherosclerosis: Site-Selective Responses to Atherosclerotic Modulators , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[32]  A. Shah,et al.  Oxidative stress in heart failure. More than just damage. , 2003, European heart journal.

[33]  R. Fechtner,et al.  Antifibrotics and wound healing in glaucoma surgery. , 2003, Survey of ophthalmology.

[34]  Jianglin Fan,et al.  Inflammatory reactions in the pathogenesis of atherosclerosis. , 2003, Journal of atherosclerosis and thrombosis.

[35]  W. MacNee,et al.  Oxidative stress and lung inflammation in airways disease. , 2001, European journal of pharmacology.

[36]  P. Kovanen,et al.  Lipolysis of LDL by Human Secretory Phospholipase A2 Induces Particle Fusion and Enhances the Retention of LDL to Human Aortic Proteoglycans , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[37]  P. Sartipy,et al.  Phospholipase A2 and small, dense low-density lipoprotein , 2000, Current opinion in lipidology.

[38]  A. Mermoud,et al.  Nonpenetrating filtering surgery in glaucoma. , 2000, Current opinion in ophthalmology.

[39]  T. Callister,et al.  Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. , 2000, Circulation.

[40]  J. Crowston,et al.  Understanding and controlling the scarring response: The contribution of histology and microscopy , 1998, Microscopy research and technique.

[41]  T. Osawa,et al.  [Oxidative stress and atherosclerosis]. , 1997, Nihon rinsho. Japanese journal of clinical medicine.

[42]  F. Parhami,et al.  Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[43]  R. Alexander.  Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. , 1995, Hypertension.

[44]  C. O'brien,et al.  Adverse effects of topical antiglaucoma medication. I. The conjunctival cell profile. , 1994 .

[45]  C. O'brien,et al.  Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. , 1994 .

[46]  S. Fowler,et al.  Nile red: a selective fluorescent stain for intracellular lipid droplets , 1985, The Journal of cell biology.

[47]  M. Murakami,et al.  Expression of secretory phospholipase A2s in human atherosclerosis development. , 2008, Atherosclerosis.

[48]  G. Skuta,et al.  Wound Healing Modulation in Glaucoma Filtering Surgery , 2004, International ophthalmology clinics.

[49]  Mark Johnson,et al.  Glaucoma surgery and aqueous outflow: how does nonpenetrating glaucoma surgery work? , 2002, Archives of ophthalmology.

[50]  A. E. Maumenee.  External filtering operations for glaucoma: the mechanism of function and failure. , 1960, Transactions of the American Ophthalmological Society.

[51]  Maumenee Ae,et al.  External filtering operations for glaucoma: the mechanism of function and failure. , 1960 .